Evidence map›Paper›PMID 33904020›Full record

ArticleMolecular neurobiology2021

The Three Glycotypes in the London Classification System of Sporadic Creutzfeldt-Jakob Disease Differ in Disease Duration.

Blair Ney, Dhamidhu Eratne, Victoria Lewis, Luke Ney, Qiao-Xin Li, Christiane Stehmann, Steven Collins, Dennis Velakoulis

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Blair NeyMelbourne Medical School, The University of Melbourne, Parkville, VIC, 3010, Australia. blair.ney3@svha.org.au.ORCID http://orcid.org/0000-0003-4026-4863
Dhamidhu EratneNeuropsychiatry Unit, Royal Melbourne Hospital, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-3226-7645
Victoria LewisAustralian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0003-2936-6308
Luke NeySchool of Medicine (Psychology), University of Tasmania, Private Bag 30, Sandy Bay, TAS, 7005, Australia.ORCID http://orcid.org/0000-0003-0209-8366
Qiao-Xin LiNational Dementia Diagnostics Laboratory, Florey Institute, The University of Melbourne, Parkville, VIC, 3052, Australia.ORCID http://orcid.org/0000-0001-8438-3763
Christiane StehmannAustralian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0001-8282-9151
Steven CollinsAustralian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-5245-6611
Dennis VelakoulisNeuropsychiatry Unit, Royal Melbourne Hospital, Parkville, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-8842-8479

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common form of CJD and is believed to be caused by the misfolding and aggregation of endogenous prion protein. Several classification systems have been developed to correlate the molecular characteristics of these misfolded prions (PrP

Indexed as

Disease ProgressionAdultAgedAged, 80 and overBiomarkersCreutzfeldt-Jakob SyndromeFemaleGlycoproteinsHumansMaleMiddle AgedPrPSc ProteinsRegistriesBiomarkersGlycoproteinsPrPSc ProteinsGlycotypeSCJDSporadic Creutzfeldt-Jakob disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.